Included: all patients who are discharged alive from inpatient care and where there is documented evidence that the patient is in atrial fibrillation on discharge are included, except where there is a ‘No but’ reason as to why the patient who was in atrial fibrillation on discharge was not discharged with a plan to start on anticoagulation within the next month.
Excluded: patients who died in inpatient care, patients where there was no evidence the patient was in atrial fibrillation on discharge, and patients in atrial fibrillation who had a ‘no but’ reason as to why the patient was not discharged with a plan to start on anticoagulation within the next month are excluded from this indicator |
Numerator = the number of patients who were discharged on anticoagulants or with a plan to start anticoagulation within the next month.
Denominator = all the patients in the cohort where there is documented evidence that the patient is in atrial fibrillation. Patients who were discharged not on anticoagulants or with a plan to start on anticoagulation but with documented evidence of being in atrial fibrillation are included in the denominator.
To calculate the numerator:
Count the number of patients who were discharged on anticoagulants (not anti-platelet agent) or with a plan to start on anticoagulants within the next month (Q 7.10.1 is ‘Yes’).
Cohort percentage:
For team-centred | For patient-centred |
All patients in the team-centred post-72h cohort who were discharged alive from inpatient care by this team with documented evidence of being in atrial fibrillation | All patients in the patient-centred post-72h cohort who were discharged alive from inpatient care with documented evidence of being in atrial fibrillation |
Example
Patient W was not discharged alive so is excluded from this indicator.
Patient X had documented evidence of being in atrial fibrillation on discharge, and was discharged on anticoagulants (or with a plan to start within the next month). Patient X therefore achieved this indicator.
Patient Y had documented evidence of being in atrial fibrillation on discharge, but was not discharged on anticoagulants (Q7.10.1=”No”). Patient Y therefore did not achieve this indicator.
Patient X had documented evidence of being in atrial fibrillation on discharge, but was not discharged on anticoagulants for a “no but” reason (Q7.10.1=”No but”). Patient Z was therefore excluded from this indicator.
Therefore the cohort percentage is 0.50 or 50% or